Abstract
In rats synthesis of some acute phase reactants can be induced by a combination of corticosteroids and adrenaline. During fever both hormones show high plasma levels. We studied the effect of fever induced by intra-cerebroventricular (i.c.v.) injection of PGE2 on the acute phase response. Fever was continuously recorded and 24 h after induction acute phase reactant (APR) response was measured as indicated by the rise of alpha-macrofetoprotein (alpha M FP, alpha 2 macroglobulin of the rat). Controls received 0.9% saline i.c.v. Controls did not develop fever (dTmax less than or equal to 1 degree C) nor did they show significant APR response. The maximal rise in body temperature after PGE2 (2.6 +/- 0.7 degrees C) correlated significantly with the rise in alpha M FP concentration 24 h later. Adrenalectomy prevented the APR response completely but the magnitude of the fever reaction remained the same (2.1 +/- 0.3 degrees C). alpha-Blockade gave a smaller fever response but had no effect on the APR response. In alpha- and beta-blockade, fever response was normal but no APR response was obtained. Destroying the sympathetic nerve supply to the liver with 6-OH dopamine retarded the fever response but again APR response was not impeded. In order to differentiate between the role of fever as such and the effect of PGE2 on APR synthesis, we used heat exposure to induce hyperthermia in normal rats who showed an APR response comparable with that after i.c.v. PGE2. Pretreatment with sodium salicylate before inducing hyperthermia led to a variable rise in alpha M FP. Fever as such, without tissue injury, induces an APR response. The pathway to this effect probably involves circulating corticosterone and adrenaline, possibly via a beta-receptor mediated stimulation.
Full text
PDF











Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bornstein D. L. Leukocytic pyrogen: a major mediator of the acute phase reaction. Ann N Y Acad Sci. 1982;389:323–337. doi: 10.1111/j.1749-6632.1982.tb22147.x. [DOI] [PubMed] [Google Scholar]
- Dinarello C. A. Interleukin-1. Rev Infect Dis. 1984 Jan-Feb;6(1):51–95. doi: 10.1093/clinids/6.1.51. [DOI] [PubMed] [Google Scholar]
- Feldberg W., Saxena P. N. Fever produced by prostaglandin E1. J Physiol. 1971 Sep;217(3):547–556. doi: 10.1113/jphysiol.1971.sp009585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoffman W. E., Albrecht R. F., Miletich D. J. Effect of sympathetic blockade on central prostaglandin E2-induced hyperthermia. Brain Res. 1986 Mar 5;367(1-2):73–76. doi: 10.1016/0006-8993(86)91580-5. [DOI] [PubMed] [Google Scholar]
- Hoffman W. E., Valigura T. J. Independence of cardiovascular and hyperthermic effects of central prostaglandin E2. Brain Res. 1979 Sep 7;173(1):160–163. doi: 10.1016/0006-8993(79)91106-5. [DOI] [PubMed] [Google Scholar]
- JONES R. S., MAYNE Y. C., EIK-NES K. C14 labeled bacterial polysaccharide and adrenal cortical function in the guinea pig. Endocrinology. 1958 Jun;62(6):843–852. doi: 10.1210/endo-62-6-843. [DOI] [PubMed] [Google Scholar]
- LAVERTY R., SHARMAN D. F., VOGT M. ACTION OF 2, 4, 5-TRIHYDROXYPHENYLETHYLAMINE ON THE STORAGE AND RELEASE OF NORADRENALINE. Br J Pharmacol Chemother. 1965 Apr;24:549–560. doi: 10.1111/j.1476-5381.1965.tb01745.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Logan R. W., Murdoch W. R. Blood-levels of hydrocortisone, transaminases, and cholesterol after myocardial infarction. Lancet. 1966 Sep 3;2(7462):521–524. doi: 10.1016/s0140-6736(66)92880-7. [DOI] [PubMed] [Google Scholar]
- Opie L. H. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. Am J Cardiol. 1975 Dec;36(7):938–953. doi: 10.1016/0002-9149(75)90086-7. [DOI] [PubMed] [Google Scholar]
- SILBER R. H., BUSCH R. D., OSLAPAS R. Practical procedure for estimation of corticosterone or hydrocortisone. Clin Chem. 1958 Aug;4(4):278–285. [PubMed] [Google Scholar]
- Spławiński J. A., Górka Z., Zacny E., Wojtaszek B. Hyperthermic effects of arachidonic acid, prostaglandin E2 and F2alpha in rats. Pflugers Arch. 1978 Apr 25;374(1):15–21. doi: 10.1007/BF00585692. [DOI] [PubMed] [Google Scholar]
- Street J. A., Hemsworth B. A., Roach A. G., Day M. D. Tissue levels of several radiolabelled beta-adrenoceptor antagonists after intravenous administration in rats. Arch Int Pharmacodyn Ther. 1979 Feb;237(2):180–190. [PubMed] [Google Scholar]
- Turchik J. B., Bornstein D. L. Role of the central nervous system in acute-phase responses to leukocytic pyrogen. Infect Immun. 1980 Nov;30(2):439–444. doi: 10.1128/iai.30.2.439-444.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Young J. B., Fish S., Landsberg L. Sympathetic nervous system and adrenal medullary responses to ischemic injury in mice. Am J Physiol. 1983 Jul;245(1):E67–E73. doi: 10.1152/ajpendo.1983.245.1.E67. [DOI] [PubMed] [Google Scholar]
- van Gool J., Boers W., Sala M., Ladiges N. C. Glucocorticoids and catecholamines as mediators of acute-phase proteins, especially rat alpha-macrofoetoprotein. Biochem J. 1984 May 15;220(1):125–132. doi: 10.1042/bj2200125. [DOI] [PMC free article] [PubMed] [Google Scholar]
